A study of 1,200 adults with solid tumors presented at ASN Kidney Week 2026 found that creatinine-based and ...

A BMC Pediatrics study finds that a random forest model combining serum creatinine and cystatin C, further improved by adding ...

New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ...

FLAURA2 shows early EGFR ctDNA clearance is prognostic but does not predict benefit from adding chemotherapy to first-line ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today presented new biomarker data from the Phase 3 PROTECT Study providing ...

Vertex Pharmaceuticals (NASDAQ:VRTX) outlined updates across its kidney disease pipeline at the American Society of Nephrology Kidney Week 2026, highlighting data for povetacicept in IgA nephropathy ...

If my doctors certify that I am in a persistent vegetative state, that is, if I am not conscious and am not aware of myself ...

Sefaxersen achieves 43% proteinuria reduction in Phase 3 IgA Nephropathy Study, targeting disease mechanisms beyond standard care in kidney disease treatment.

Genmab will run a Phase 1/2 trial of petosemtamab, Incyte’s KRAS G12D inhibitor and chemotherapy; trial timing and endpoints remain undisclosed.

New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients ...

COCOON shows lazertinib lead-in plus simplified prophylaxis reduced grade ≥2 skin toxicity to 18% with SC amivantamab in EGFR ...

While there are many aspects of CKD dietary therapy that are difficult in practice, I believe there are many points to ...